Genetic deletion of placenta growth factor in mice alters uterine NK cells

Journal of Immunology

Volumn 178, Issue 7, 2007, Pages 4267-4275

  Tayade, Chandrakant ^a,d   Hilchie, David ^a   He, Hong ^a   Fang, Yuan ^a   Moons, Lieve ^b   Carmeliet, Peter ^b   Foster, Robert A ^a   Croy, B Anne ^a,c  

^a UNIVERSITY OF GUELPH   (Canada)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; PLACENTAL GROWTH FACTOR; RAG2 PROTEIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DECIDUA; ENDOMETRIUM; GENE DELETION; IMMUNOHISTOLOGY; MOUSE; NATURAL KILLER CELL; NIDATION; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST; UTERUS;

EID: 33947615885     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.7.4267     Document Type: Article

References (42)

1. Ziche, M., D. Maglione, D. Ribatti, L. Morbidelli, C. T. Lago, M. Battisti, I. Paoletti, A. Barra, M. Tucci, G. Parise, et al. 1997. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab. Invest. 76: 517-531.
2. Autiero, M., J. Waltenberger, D. Communi, A. Kranz, L. Moons, D. Lambrechts, J. Kroll, S. Plaisance, M. De Mol, F. Bono, et al. 2003. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9: 936-943.
3. Carmeliet, P., L. Moons, A. Luttun, V. Vincenti, V. Compernolle, M. De Mol, Y. Wu, F. Bono, L. Devy, H. Beck, et al. 2001. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7: 575-583.
4. Clark, D. E., S. K. Smith, D. Licence, A. L. Evans, and D. S. Charnock-Jones. 1998. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J. Endocrinol. 159: 459-467.
5. Li, X. F., D. S. Charnock-Jones, E. Zhang, S. Hiby, S. Malik, K. Day, D. Licence, J. M. Bowen, L. Gardner, A. King, et al. 2001. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J. Clin. Endocrinol. Metab. 86: 1823-1834.
6. Lash, G. E., B. Schiessl, M. Kirkley, B. A. Innes, A. Cooper, R. F. Searle, S. C. Robson, and J. N. Bulmer. 2006. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukocyte Biol. 80: 572-580.
7. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2: 656-663.
8. Hanna, J., D. Goldman-Wohl, Y. Hamani, I. Avraham, C. Greenfield, S. Natanson-Yaron, D. Prus, L. Cohen-Daniel, T. I. Arnon, I. Manaster, et al. 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12: 1065-1074.
9. Langer, N., D. Beach, and E. S. Lindenbaum. 1999. Novel hyperactive mitogen to endothelial cells: human decidual NKG5. Am. J. Reprod. Immunol. 42: 263-272.
10. Hiby, S. E., J. J. Walker. K. M. O'Shaughnessy, C. W. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965.
11. Torry, D. S., H. S. Wang, T. H. Wang, M. R. Caudle, and R. J. Torry. 1998. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am. J. Obstet. Gynecol. 179: 1539-1544.
12. Levine, R. J., R. Thadhani, C. Qian, C. Lam, K. H. Lim, K. F. Yu, A. L. Blink, B. P. Sachs, F. H. Epstein, B. M. Sibai, et al. 2005. Urinary placental growth factor and risk of preeclampsia. J. Am. Med. Assoc. 293: 77-85.
13. Venkatesha, S., M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y. M. Kim, Y. Bdolah, K. H. Lim, H. T. Yuan, T. A. Libermann, et al. 2006. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12: 642-649.
14. Tayade, C., G. P. Black, Y. Fang, and B. A. Croy. 2006. Differential gene expression in endometrium, endometrial lymphocytes, and trophoblasts during successful and abortive embryo implantation. J. Immunol. 176: 148-156.
15. Leonard, S., C. Murrant, C. Tayade, M. van den Heuvel, R. Watering, and B. A. Croy. 2006. Mechanisms regulating immune cell contributions to spiral artery modification: facts and hypotheses-a review. Placenta 27(Suppl. A): S40-S46.
16. Wang. C., N. Umesaki, H. Nakamura, T. Tanaka. K. Nakatani, I. Sakaguchi, S. Ogita, and K. Kaneda. 2000. Expression of vascular endothelial growth factor by granulated metrial gland cells in pregnant murine uteri. Cell Tissue Res. 300: 285-293.
17. Wang, C., T. Tanaka, H. Nakamura, N. Umesaki, K. Hirai, O. Ishiko, S. Ogita, and K. Kaneda. 2003. Granulated metrial gland cells in the murine uterus: localization, kinetics, and the functional role in angiogenesis during pregnancy. Microsc. Res. Tech. 60: 420-429.
18. Guimond, M. J., B. Wang, and B. A. Croy. 1998. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tgε 26 mice. J. Exp. Med. 187: 217-223.
19. Ashkar, A. A., J. P. Di Santo, and B. A. Croy. 2000. Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192: 259-270.
20. Peel, S. 1989. Granulated metrial gland cells. Adv. Anat. Embryol. Cell Biol. 115: 1-112.
21. Paffaro, V. A., Jr., M. C. Bizinotto, P. P. Joazeiro, and A. T. Yamada. 2003. Subset classification of mouse uterine natural killer cells by DBA lectin reactivity. Placenta 24: 479-488.
22. Bulmer, J. N., and G. E. Lash. 2005. Human uterine natural killer cells: a reappraisal. Mol. Immunol. 42: 511-521.
23. Croy, B. A., S. Esadeg, S. Chantakru, M. van den Heuvel, V. A. Paffaro, H. He, G. P. Black, A. A. Ashkar, Y. Kiso, and J. Zhang. 2003. Update on pathways regulating the activation of uterine natural killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J. Reprod. Immunol. 59: 175-191.
24. Tayade, C., Y. Fang, G. P. Black, V. A. Paffaro, Jr., A. Erlebacher, and B. A. Croy. 2005. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells. J. Leukocyte Biol. 78: 1347-1355.
25. Taylor, R. N., J. Grimwood, R. S. Taylor, M. T. McMaster, S. J. Fisher, and R. A. North. 2003. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol. 188: 177-182.
26. Thadhani, R., W. P. Mutter, M. Wolf, R. J. Levine, R. N. Taylor, V. P. Sukhatme, J. Ecker, and S. A. Karumanchi. 2004. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J. Clin. Endocrinol. Metab. 89: 770-775.
27. Torry, D. S., D. Mukherjea, J. Arroyo, and R. J. Torry. 2003. Expression and function of placenta growth factor: implications for abnormal placentation. J. Soc. Gynecol. Investig. 10: 178-188.
28. Bersinger, N. A., and R. A. Odegard. 2005. Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for-gestational age birth. Am. J. Reprod. Immunol. 54: 77-83.
29. Krauss, T., H. U. Pauer, and H. G. Augustin. 2004. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens. Pregnancy 23: 101-111.
30. Solomon, C. G., and E. W. Seely. 2004. Preeclampsia: searching for the cause. N. Engl. J. Med. 350: 641-642.
31. Maglione, D., V. Guerriero, G. Viglietto, M. G. Ferraro, O. Aprelikova, K. Alitalo, S. Del Vecchio, K. J. Lei, J. Y. Chou, and M. G. Persico. 1993. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8: 925-931.
32. Cao, Y., W. R. Ji, P. Qi, A. Rosin, and Y. Cao. 1997. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem. Biophys. Res. Commun. 235: 493-498.
33. Ghosh, D., A. M. Sharkey, D. S. Charnock-Jones, L. Dhawan, S. Dhara, S. K. Smith, and J. Sengupta. 2000. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey. Mol. Hum. Reprod. 6: 935-941.
34. Achen, M. G., J. M. Gad, S. A. Stacker, and A. F. Wilks. 1997. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors 15: 69-80.
35. Rossant, J., and B. A. Croy. 1985. Genetic identification of tissue of origin of cellular populations within the mouse placenta. J. Embryo. Exp. Morphol. 86: 177-189.
36. Ishida, A., J. Murray, Y. Saito, C. Kanthou, O. Benzakour, M. Shibuya, and E. S. Wijelath. 2001. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J. Cell. Physiol. 188: 359-368.
37. Delgado, S. R., B. A. McBey, S. Yamashiro, J. Fujita, Y. Kiso, and B. A. Cray. 1996. Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J. Leukocyte Biol. 59: 262-269.
38. Maglione, D., V. Guerriero, G. Viglietto, P. Delli-Bovi, and M. G. Persico. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA 88: 9267-9271.
39. Hirashima, M., Y. Lu, L. Byers, and J. Rossant. 2003. Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta. Proc. Natl. Acad. Sci. USA 100: 15637-15642.
40. Vosshenrich, C. A., M. E. Garcia-Ojeda, S. I. Samson-Villeger, V. Pasqualetto, L. Enault, O. Richard-Le Goff, E. Corcuff, D. Guy-Grand, B. Rocha, A. Cumano, et al. 2006. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7: 1217-1224.
41. Di Santo, J. P. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24: 257-286.
42. Ashkar, A. A., G. P. Black, Q. Wei, H. He, L. Liang, J. R. Head, and B. A. Croy. 2003. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J. Immunol. 171: 2937-2944.